Results 241 to 250 of about 2,857,482 (280)

Management Principles Associated With Cytokine Release Syndrome

Seminars in Oncology Nursing, 2019
To discuss current recommendations and resources for nurses to ensure they advocate for patients with cytokine release syndrome (CRS).A literature search using key terms: cytokine release syndrome, neurotoxicity, CAR T, adverse events.Chimeric antigen receptor (CAR) T-cell immunotherapy is a growing and rapidly changing field of research.
Brittney, Baer, Channing Vail, Dudley, Rhea Micci, Simons   +2 more
openaire   +2 more sources

Monoclonal antibody-induced cytokine-release syndrome

Expert Review of Clinical Immunology, 2009
Monoclonal antibodies (mAbs) are widely used in anti-inflammatory and tumor therapy. Although effective, mAbs can cause a variety of adverse effects. An important toxicity seen with a few mAbs is cytokine-release syndrome (CRS). These mAbs include: alemtuzumab, muromonab-CD3, rituximab, tosituzumab, CP-870,893, LO-CD2a/BTI-322 and TGN1412. By contrast,
Peter J, Bugelski, Ram, Achuthanandam, Renold J, Capocasale, George, Treacy, Esther, Bouman-Thio   +4 more
openaire   +2 more sources

Cytokine release syndrome: a primer for generalists

Adverse Drug Reaction Bulletin, 2019
Summary Cytokine release syndrome (CRS) is an adverse drug reaction that is poorly understood but is likely to be increasingly common as more immunotherapeutics are being developed and licensed, principally in the treatment of cancer.
Tiago Soares, Henry Fok
openaire   +1 more source

Cytokine-Release Syndrome: Overview and Nursing Implications

Clinical Journal of Oncology Nursing, 2007
Cytokine-release syndrome is a symptom complex associated with the use of many monoclonal antibodies. Commonly referred to as an infusion reaction, it results from the release of cytokines from cells targeted by the antibody as well as immune effector cells recruited to the area.
openaire   +2 more sources

Understanding cytokine release syndrome

Intensive Care Medicine, 2017
Philipp Gödel, Alexander Shimabukuro-Vornhagen, Michael von Bergwelt-Baildon   +2 more
openaire   +2 more sources

Management of Cytokine Release Syndrome

2020
Indumathy Varadarajan, Tamila L. Kindwall-Keller, Daniel W. Lee   +2 more
openaire   +2 more sources

Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature

Immunological Investigations, 2021
Payam Tabarsi, Davood Mansouri, Nahal Mansouri   +2 more
exaly  

Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality

International Reviews of Immunology, 2022
Xudong Wu, Qinyong Hu, Lei Tu
exaly  

Interleukin-6 and cytokine release syndrome

Annals of Allergy, Asthma & Immunology, 2023
Erika Yue Lee, Baruch D. Jakubovic
openaire   +1 more source

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

International Journal of Antimicrobial Agents, 2020
Zhao Wu, Hong Zhao, Chi Zhang
exaly